Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Kunming Yusi Pharmaceutical is a Chinese pharmaceutical company headquartered in Kunming, Yunnan Province, specializing in the manufacture of generic Western medicines and Traditional Chinese Medicine (TCM). The company's product portfolio primarily addresses common ailments, featuring widely distributed treatments for the common cold, bacterial infections, and inflammatory conditions. Operating from a GMP-certified facility in the Kunming High-tech Industrial Development Zone, it produces various dosage forms including capsules, tablets, and granules. Yunnan Kunming Yusi Pharmaceutical is a significant contributor to the regional healthcare supply chain, providing essential medications like Amoxicillin and Compound Paracetamol to the domestic Chinese market. The company is recognized as a high-tech enterprise within its province, focusing on quality control and the production of cost-effective therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Kunming Yusi Pharmaceutical.